{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:09:07Z","timestamp":1783699747126,"version":"3.55.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RO1 DA016159"],"award-info":[{"award-number":["RO1 DA016159"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA021550"],"award-info":[{"award-number":["R01 DA021550"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA029512"],"award-info":[{"award-number":["R01 DA029512"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["T32 HS000066"],"award-info":[{"award-number":["T32 HS000066"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177341","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T19:37:44Z","timestamp":1495741064000},"page":"e0177341","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2846-9762","authenticated-orcid":true,"given":"Benjamin","family":"Eckhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Winkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla A.","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Carden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don C.","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall J.","family":"Glesby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Edlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"issue":"Suppl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/cid\/cis393","article-title":"Evolving epidemiology of hepatitis C virus in the United States","volume":"55","author":"RM Klevens","year":"2012","journal-title":"Clin Infect Dis. United States"},{"key":"ref2","article-title":"Rising Mortality Associated With Hepatitis C Virus in the United States, 2003\u20132013","author":"KN Ly","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21765","article-title":"Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000","volume":"46","author":"F-C Tseng","year":"2007","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","article-title":"Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses","volume":"86","author":"RS Garfein","year":"1996","journal-title":"Am J Public Health. UNITED STATES"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2105\/AJPH.91.1.46","article-title":"Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif","volume":"91","author":"J Lorvick","year":"2001","journal-title":"Am J Public Health. United States"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","article-title":"Correlates of hepatitis C virus infections among injection drug users","volume":"74","author":"DL Thomas","year":"1995","journal-title":"Medicine (Baltimore). UNITED STATES"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21765","article-title":"Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000","volume":"46","author":"F-C Tseng","year":"2007","journal-title":"Hepatology. United States"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"H Hagan","year":"1999","journal-title":"Am J Epidemiol. UNITED STATES"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5694\/j.1326-5377.1990.tb136900.x","article-title":"Hepatitis C virus in intravenous drug users","volume":"153","author":"J Bell","year":"1990","journal-title":"Med J Aust. AUSTRALIA: Westmead Hospital, NSW"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1097\/QAD.0b013e3283578b5d","article-title":"Estimating the cost-effectiveness of needle-syringe programs in Australia","volume":"26","author":"JA Kwon","year":"2012","journal-title":"AIDS. England"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/474S18a","article-title":"Perspective: test and treat this silent killer","volume":"474","author":"BR Edlin","year":"2011","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":"Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment","volume":"155","author":"LE Thorpe","year":"2002","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/345554","article-title":"Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks","volume":"186","author":"JA Hahn","year":"2002","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"ref14","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/cid\/cit300","article-title":"Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention","volume":"57","author":"K Page","year":"2013","journal-title":"Clin Infect Dis. United States"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.03.039","article-title":"Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006\u20132013","volume":"152","author":"AE Jordan","year":"2015","journal-title":"Drug Alcohol Depend. Ireland"},{"key":"ref16","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged <30 years\u2014Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012","volume":"64","author":"JE Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep. United States"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"PJ Peters","year":"2016","journal-title":"N Engl J Med. Massachusetts Medical Society"},{"key":"ref18","article-title":"Vital Signs: Demographic and Substance Use Trends Among Heroin Users\u2014United States, 2002\u20132013","volume":"64","author":"CM Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref19","unstructured":"CDC Division of Viral Hepatitis. Viral Hepatitis Surveillance. 2014."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"AG Suryaprasad","year":"2014","journal-title":"Clin Infect Dis. United States"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s10900-015-0016-2","article-title":"Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study","volume":"40","author":"M Schulte","year":"2015","journal-title":"J Community Health. Netherlands"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/JCM.35.12.3274-3277.1997","article-title":"Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland","volume":"35","author":"S a Villano","year":"1997","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/jhep.2001.25759","article-title":"Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco","volume":"34","author":"J a. Hahn","year":"2001","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2105\/AJPH.91.1.23","article-title":"Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City","volume":"91","author":"T Diaz","year":"2001","journal-title":"Am J Public Health"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"H Hagan","year":"2011","journal-title":"J Infect Dis"},{"key":"ref26","unstructured":"NYSDOH\/AIDS Institute\u2014Harm Reduction Unit. NYS-Authorized Syringe Exchange Programs. 2015."},{"key":"ref27","article-title":"Trends in the Population Prevalence of People Who Inject Drugs in US Metropolitan Areas 1992\u20132007","volume":"8","author":"B Tempalski","year":"2013","journal-title":"Trends in the Population Prevalence of People Who Inject Drugs in US Metropolitan Areas 1992\u20132007"},{"key":"ref28","first-page":"2412","article-title":"More Rare Birds, and the Occasional Swan","volume":"136","author":"BR Edlin","year":"2009","journal-title":"Gastroenterology. AGA Institute American Gastroenterological Association"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsat.2014.07.002","article-title":"Injection and sexual HIV\/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City","volume":"48","author":"P Mateu-Gelabert","year":"2015","journal-title":"J Subst Abuse Treat. United States"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1007\/s10461-015-1048-4","article-title":"The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland","volume":"19","author":"A Mihailovic","year":"2015","journal-title":"AIDS Behav. United States"},{"issue":"Suppl 1","key":"ref31","first-page":"19","article-title":"Outreach-based HIV prevention for injecting drug users: a review of published outcome data","volume":"113","author":"SL Coyle","year":"1998","journal-title":"Public Health Rep. UNITED STATES"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jurban\/jti053","article-title":"Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study","volume":"82","author":"KH Seal","year":"2005","journal-title":"J Urban Health. United States"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0064321","article-title":"The Burgeoning HIV\/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV\/HCV Coinfection in an Urban Setting","volume":"8","author":"JP Morano","year":"2013","journal-title":"PLoS One"},{"key":"ref34","first-page":"1997","article-title":"Hepatitis C Virus Infection: Prevalence, Risk Factors, and Prevention Opportunities among Young Injection Drug Users in Chicago, 1997\u20131999","author":"LE Thorpe","year":"1999","journal-title":"Hepatitis C Virus Infection: Prevalence, Risk Factors, and Prevention Opportunities among Young Injection Drug Users in Chicago, 1997\u20131999"},{"key":"ref35","unstructured":"Pouget ER, McKnight C, Des Jarlais DC, Hagan H. Housing instability and hepatitis C seroconversion among injection drug users: A meta-analytic review. APHA 139th Annual Meeting and Exposition. Washington DC; 2011. p. #246814."},{"key":"ref36","unstructured":"Foderaro L. Ithaca\u2019s Anti-Heroin Plan: Open a Site to Shoot Heroin. New York Times. 2016: A1."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: A retrospective population-based study","volume":"377","author":"BD Marshall","year":"2011","journal-title":"Lancet. Elsevier Ltd"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: What has been demonstrated? A systematic literature review","volume":"145","author":"C Potier","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e008958","DOI":"10.1136\/bmjopen-2015-008958","article-title":"A police education programme to integrate occupational safety and HIV prevention: protocol for a modified stepped-wedge study design with parallel prospective cohorts to assess behavioural outcomes","volume":"5","author":"SA Strathdee","year":"2015","journal-title":"BMJ Open"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2011.05.034","article-title":"Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions","volume":"119","author":"L Beletsky","year":"2011","journal-title":"Drug Alcohol Depend. Elsevier Ireland Ltd"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T15:32:00Z","timestamp":1602171120000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177341"}},"subtitle":[],"editor":[{"given":"Georgios \u039a","family":"Nikolopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177341","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]}}}